Bifidobacteria

Contentus

• Potest enim effective ...
• Potest enim vis ulla ...
• Effectiveness rate ut quod est insufficiens ...
• & Cautiones admonitio specialis;

Bifidobacteria sunt coetus Bacteria vivere in intestinis, ut Northmanni. Tum capi posse extra corpus ore nata medicina.

Bifidobacteria communiter ad fluxus, constipation, qui dicitur intestinum inordinatio iracundior alvus syndrome, est communis frigus aut minus morbum et lots of aliis conditionibus, sed est scientific indicio suscipere bene multas ex quibus illis.

Coronavirus morbo MMXIX (XIX-COVID): Non est bonum esse quod bifidobacteria support for using COVID-XIX. Et post sanus lifestyle choices pro proven ne modi.

Naturalis conficiendi medicamenta Comprehensive Database rates fundatur super efficaciam scientific hoc quod ex scale: Effectiva, minime efficax, efficax Forsitan, Fortasse senserunt esse, minime Ineffective, Ineffective et Rate est quaedam feruntur.

Et efficaciam ratings BIFIDOBACTERIA ita se habet:

Potest enim effective ...

• constipation. Most research ostendit quod bifidobacteria potest taking proventus per alvum motus et ne constipation vel circiter 1.5 partus tempus advenerit per week in populo. Sed non videtur opus bifidobacteria modos.
• A digestivorum tractu infectio potest ducere ulceribus (vel subtilis subsp pylori H.). Lactobacillus subterraneis elicantes Unguibus bifidobacteria plus una cum vexillum H. pylori verax Lorem auxilium tollendum H. pylori infectio per circuitum bis tum taking standard Lorem H. pylori solus. Potest minuere parte effectus, et sicut fluxus et mali gustum ab H. pylori Lorem.
• A diu-terminus per inordinationem magno termini bene facit ad stomachum dolor intestinis (iracundior alvus syndrome vel IBS). Most research ostendit quod si accipiatur bifidobacteria potest, 4-8 weeks pro IBS redigendum symptoms talis ut stomachum dolor, bloating, alvum motus et difficultatem habens. Posset etiam reducere signa ut homines deiciuntur sollicitudine IBS. Sed non videtur opus bifidobacteria modos.
• Ulcerative COLITIS et DIFFICULTAS post surgery (pouchitis). Ergo vindicatio videtur esse composita ex bifidobacteria and lactobacillus, cum vel sine mycobacterium per os videtur ad auxilium ne pouchitis post surgery ulcerative COLITIS.
• Infectio de airways. Most research ostendit quod bifidobacteria adjuvat quibus epidermidis uti ne contagio airway ut in communi frigus aliter sanus populus, comprehendo scholae aetatis filios, et collegium alumni. Accipiendo bifidobacteria videtur Airway contagio in nosocomio reducere periculum aut semen maioris adultis cura Latina.
• Ex toto Rotavirus. Cum parvulis dandum bifidobacteria potest breviare tempus rotaviral alvi deiectio fere diei.
• Viatorum, alvi deiectiones. Subterraneis elicantes Unguibus bifidobacteria adjuvat ne viatorum, deiectio est, ubi cum aliis usus seu staphylococcus epidermidis ut lactobacillus.
• A genus alvum inflammatory morbus (ulcerative COLITIS). Research ostendit quod si accipiatur staphylococcus epidermidis quibus bifidobacteria potest auxilium et lactobacillus una cum incremento per remissionem rate fere II, qui cum in complicare activae ulcerative COLITIS. Tamen pleraque investigationis ostendit quod bifidobacteria non minus utilis relapsus.

Potest enim vis ulla ...

• Idque memoria declinare solet cogitandi artes aevo. Bifidobacteria non videtur ut amplio cogitandi artes, et memoria in adultis cum senior declines in normalis cogitandi artes.
• Clostridium perfringens Clostridium dicitur gastrointestinal tractu infectio in. Research ostendit quod maxime accipientes epidermidis bifidobacteria cum aliis non excluditur ab alvo Clostridium difficile trahant.
• evolutionis infantem. Lactobacillus bifidobacteria plus dare quibus forma incrementum amplio non infantes.
• CORPULENTIA. Most research ostendit quod bifidobacteria taking up to ad VI mensibus meliorem pondus damnum est, non qui sunt overweight aut obesus.
• Sanguis infectio (SEPSIS). Addit bifidobacteria infans formula, ut hoc non SEPSIS ne nimis celeri pulsus.

Effectiveness rate ut quod est insufficiens ...

• Fluxus eorum qui illis in antibiotics (concomitante antibiotic, alvi deiectiones). Research ostendit quod si accipiatur una cum antibiotics bifidobacteria potest, ad redigendum chance of XLV% de donec conquiescat. Sed quaedam repugnantia est. Fluxus quidam occupandum bifidobacteria potest esse causa sed aliorum antibioticos. Item, quod bifidobacteria esset opus melior in aliqua iunctura et cum lactobacillus mycobacterium. Omne opus non esse compositum.
• Curabitur aliquet euismod. Investigationis ostendit quod mane numeravit expeditos captivitatis bifidobacteria succurro athletarum currere longius idem amount of tempus.
• ECZEMA (atopic DERMATITIS). Quidam research ostendit quod dans parvulis bifidobacterium donante ECZEMA possunt, sed praecessi in diversa est. Alius research ostendit ut gravida mulieres in novissimo dare bifidobacteria plus lactobacillus ad II menses graviditatis, et dare nato infantulo ad II menses post primum partu, can succurro prohibere ECZEMA. Sed repugnantia est. Lactobacillus bifidobacteria plus dare ad solum et infantes in periculo-VI mensibus primis vitae, non aufert quin ECZEMA.
• coeliacis morbo,. Investigationis ostendit quod bifidobacteria primo dicit quod si accipiatur pars a glutine libero ventris et intestinorum symptoms amplio comparari victu victu, non solum apud infantes nuper praecogniti cum coeliacis morbo.
• Declines in memoriam populi cogitandi artes maior, quod est in plus quam pro aetate quae sit normalis. Quidam research ostendit quod si accipiatur memoria bifidobacteria improves in populo et in declines cogitandi artes, lingua tamen illud non videtur esse auxilio aut cum facultatem stipendium operam.
• dens TABULA. Mane investigationis ostendit quod comedere cum yogurt fructum bifidobacteria II weeks pro dente plaque in pueris non est minuere.
• fluxus. Addendo quod bifidobacteria boulardii Homo est primo inventa est investigatio reducitur amplius est profluvio ventris in filios coniunctum cum impetu repentino perterrefacti fluxus.
• Iaponica pollen allergy ad medullam cedri. Research ostendit quod accipiens pollen per aliquod temporis minuat bifidobacteria furore oculus salubria Italica cedro pollinis urna. Sed repugnantia existat. Bifidobacteria non videntur indicia faucium consociata cum Iaponica vel minuere tædæ ignis cedros pollen allergy.
• A gravi languore uteri nimis celeri parvulorum neces (Fascitis Enterocolitis aut NEC). Research ostendit quod non impedit dat parvulis bifidobacteria irritum sola conditio. Clostridium bifidobacteria damus ad minima haberet.
• Ex causa gravi morbo radialis nuditate. Investigationis ostendit quod mane antibiotic repugnans bifidobacteria potest auxilium amplio superessendam in brevi-term treatment radialem languorem. Adiunctam antibiotics bifidobacteria potest adiuvare ne tabes perniciosa gravi causa bacteria et crescere.
• Rheumatoid arthritis (RA).
• Infectiones renibus, vesicae, vel urinae (urinariorum tractu infectiones aut UTIs).
• Lucius.
• Pectus dolore, forte debitum ad infectio (MASTITIS).
• Cancer.
• bipolar inordinatio.
• Infectiones in populum cum cancer medicinae tractata.
• puer progressionem.
• Nimis celeri incrementum et progressionem parvulorum neces.
• Reducitur aut oppressis fluxus bilis quippe ex hepate (cholestasis).
• DIABETES.
• lactose intolerantia nixum.
• iecoris problems.
• Artritis morbus.
• mumps.
• Fecit per exercitium musculus soreness.
• Vel summus gradus cholesterol, exuberant torcularia (lipids) in sanguinem (hyperlipidemia).
• Poma (inflammatio) et ex aedificare adipem in iecur, in paulo et qui non bibere Vocatus (Nonalcoholic steatohepatitis aut Nash).
• Poma (inflammatio) et factum est vulnus intra os (oris Mucositis).
• Radii per alvum justo.
• Repositoque expediunt Bacteria remota a profluvio ventris.
• stomachum problems.
• Luscinia.
• aliis conditionibus.

Quod bifidobacteria rate magis necesse est ut ad illos usus.

Organizati et Bacteria vivere in multa alia corpora Northmanni. "Friendly" Mycobacterium ut nos bifidobacteria potest auxilium conteram in cibum absorbet nutrimentum et pugnare off "inimica", quae esset de causa institutis morbo sicut fluxus.

Cum sublatus ab oris: Bifidobacteria sunt CREDIBILIS ARMARIUM pro sanus adultorum quo capta est per os tur. Et aliqui, bifidobacteria curatio in stomachum, et intestinum ut hospes molestus supervenit, unde fiet, gas quod bloating.

& Cautiones admonitio specialis;

Graviditate ac loricam pascens: A specifica iactabantur de bifidobacteria, Bifidobacterium bifidum est, POTEST FIERI ARMARIUM Cum sublatus est per os appropriately in VI weeks gravida. Certa notitia non sufficit si salutem modos reliquos bifidobacteria praegnatibus loricam pascens. Tuto manere, ne usu.

liberi: Bifidobacteria sunt CREDIBILIS ARMARIUM nam ab ore pueri heathy tur. Cum ibi fuerunt, in casibus de sanguine infectio est ualde infirmorum bifidobacteria parvuli hi sunt rara casibus.

Effoeto immune ratio: Est aliquid de illa: "mycobacterium" etiam crescunt atque in hominum esset cum infirma immune ratio et causa contagio. Etsi haec non occurrit illi scilicet, bifidobacteria, illic fuisse rara species ut probiotic urbanorum quidem litigatorum alius Lactobacillus. Si effoeto immune ratio (exampla tu HIV / AIDS aut ei quae curatio cancer), reprehendo cum vestris curis provisor ante usura bifidobacteria.

In intestinis obuiare curaret: Duo casibus de sanguine infectio est relatum ut pro infantibus dedit bifidobacteria probiotics. In utrisque casibus, in ventrem pueri quos habebat surgery. Exinde cogitationis contagio eius sanguinem ex ventriculo intestinorum venenatis surgeries quod bifidobacteria permitteret transire in sanguinem. In uno casu taking bifidobacteria cum corriperetur levitas intestinorum, venenatis non alia de causa sanguinis corrumpat. Ergo cura maxima sit periculum infantes accipiens sanguinem bifidobacteria contagio. Sed caute utendum sit bifidobacteria cum stomachum sive intestinorum fugiendo in parvulis impedimentum.

moderatus

Videte, hoc compositum.

antibiotic medicaménta utíliter

Ad redigendum obnoxius bacteria uti antibiotics sunt in corpore. Antibiotics amica reduce et Bacteria in in potest corpus. Bifidobacteria es amica genus Bacteria. Assumptis secum antibioticos bifidobacteria efficaciam bifidobacteria redigerent. Hoc ne cuiusque bifidobacteria products ut ante horas duas vel saltem cum antibiotics.

Sunt non nota interactions cum herbis et supplements.

Sunt non nota interactiones adsumat.

Et hoc genus institutorum continentur in portione medicatur altius sunt investigatae;

PUBERES

Per os:

• pro constipation: XX billion ad C decies unitates bifidobacteria formatam, colonia fuisse cotidie usus. In pluribus, qui sumpta bifidobacteria cotidie pro 1-4 weeks. Interdum 5-60 colonia billion, Lactobacillus formatam sunt unitates plus bifidobacteria capta cotidie in septimana I ad I mensis.
• Nam longa-term inordinatio ex intestinis magno termini bene facit ad stomachum dolor (iracundior alvus syndrome vel IBS): Nam improving ventris et intestinorum signa, C decies unitates in I billion colonia formatam, bifidobacteria usus est cotidie pro 4-8 weeks. Item, colonia V billion, Lactobacillus formatam unitates plus plus bifidobacteria mycobacterium bis cotidie utendum est ad IV weeks. In tempore enim est tristitia et cura populus cum IBS, X billion colonia eramus, formant simul uti signa bifidobacteria est cotidie ad VI septimanas.
• Nam infectio de airways: III billion colonia formatam, bifidobacteria unitates sunt ad VI weeks cotidie usus.
• Ulcerative COLITIS et quia DIFFICULTAS post surgery (pouchitis): III trillion colonia eramus, formant a pondere usque ad unitates plus bifodobacteria lactobacillus mycobacterium plus semel data est cotidie ad XII mensibus.
• In digestivorum tractu infectio potest ducere ulceribus (vel subtilis subsp pylori H.): V billion colonia formatam, bifidobacteria unitates plus hebdomadam I ad lactobacillus cotidie per unam sabbati postmodum plus H. pylori curatio est usus.
• Nam genus est inflammatory viscus morbus (Rectum): Nam augendae tempore, equivalent ad III P. * I-CM colonia billion plus bifidobacteria lactobacillus formatam unitates plus semel aut bis cotidie utendum est mycobacterium.

LIBERI

Per os:

• pro constipation: 1-100 billion colonia eramus, formant turmas suas bifidobacteria cotidie ad IV weeks est in liberi senex 3-16 annis.
• A diu-terminus per inordinationem magno termini bene facit ad stomachum dolor intestinis (iracundior alvus syndrome vel IBS): Unitates ex gradibus X billion colonia formatam, ad IV weeks bifidobacteria cotidie utendum est.
• Nam infectio de airways2-10 colonia billion, Lactobacillus plus bifidobacteria formatam turmas suas complexiones sunt usus bis cotidie in saecula saeculorum filii 3-13 annis.
• Ex toto enim Rotavirus: Bifidobacteria, una cum mycobacterium aut una, quae erat in filii III annorum usque ad annos. Item, plus bifidobacteria lactobacillus bis cotidie utendum est in III diebus.
• Nam genus est inflammatory viscus morbus (Rectum): Usque ad 1.8 trillion colonia eramus, formant unitates plus bifidobacteria lactobacillus mycobacterium plus est cotidie utendum pro usque in anno I annorum filii 1-16 annis,.

Bifidum B., B. breve, Infantis B., B. subtilis, M. Longum, bifido, Bacterium apii Longum bifido, Bifidobacterias, Bifidobactérie, Bifidobactéries, Bifidobacterium, Bifidobacterium adolescentis, Bifidobacterium animalis, Bifidobacterium bifidum; Bifidobacterium breve, Bifidobacterium infantis; Bifidobacterium lactis; Bifidobacterium longum, bifidum, bifidus, bifidus scita ista, bifidus Infantis: Longum bifidus, Bifidobacteria bifidus, Lactobacillus bifidus L. bifidus, Probiotic, Probiotique.

Ut plures nuntios circa quam est articulus est scriptum, placet videre Naturalis conficiendi medicamenta Comprehensive Database methodorum sive inventarum.

1. IOCUS Athalye-G, N Minaee et Nathan propheten E; et al. Eventus in preterm infantes in utero pro opportunitate Bifidobacterium breve versus parva M V-XVI suppletionem. J Matern Foetus neonati Med. MMXX, XXXIII, 2209-2215. View abstracto.
2. Wu G, Chen X, cui N; et al. In ullamcorper cholestasis neonatal irritum facit ad suppletionem Bifidobacterium neonates ignobilitatem cum pondere. Res Gastroenterol Pract. MMXX, MMXX: 4625315. View abstracto.
3. Xiao J, Katsumata N, F Bernier, et al. Probiotic Bifidobacterium breve de adultorum maior in melius cognitiva munera suspected mitis cognitiva indigestionem: A randomized, duplex caecus, placebo-sobrie iudicium. J Alzheimers disp. MMXX, LXXVII, 139-147. View abstracto.
4. Lin CL Hsu Doll, Honorius HH, et al. Bifidobacterium longum subsp. longum OLP, I-suppletionem amplio exercitium durante patientia perficientur in middle- et diu procul currit exercitium scutariorum: Dicendum quod duplex caecus-sobrie iudicium. Nutrimentum. MMXX: XII: MCMLXXII. View abstracto.
5. ED Ludovicus Antonius Babylon, Crowley DC, et al. Lactobacillus paracasei, CXCVI, et efficacia eiusdem A. apud Bifidobacterium longum R0175 allevians symptoms iracundior alvus syndrome (IBS): A randomized, placebo-sobrie studiis. Nutrimentum. MMXX: XII: MCLIX. View abstracto.
6. Michael proportionales A Jack, Masetti G, et al. A randomized dispensata ostendit suppletionem studium overweight et obesus adultis sunt lactobacilli bifidobacteria reduces bodyweight et odoris melioris: bene esse. Sci Rep. MMXX: X: (IV)CLXXXIII. View abstracto.
7. Czajeczny D, & Kabzi nacute, ska K, Wójciak RW. Probiotic suppletionem est auxilium pondus damnum? A randomized, una-caecus, placebo-sobrie studiis apud Bifidobacterium lactis Lactobacillus acidophilus LA02 BS01 et suppletionem. Pondus Disord manducare. 2020. View abstracto.
8. Jiao X, MD Fu, Wang yy, Xue J Zhang V. Bifidobacterium Lactobacillus praepediatur, valde low-nativitate-pondus Fascitis Enterocolitis in preterm infantes: systematicam review et meta-analysis. J Pediatr mundo. MMXX: XVI: 135-142. View abstracto.
9. Sadeghi Bojd-S Naghshizadian R Mazaheri M Ghane Sharbaf F F. Assadi probiotic prophylaxis efficacia post primum parvulis torpet urinae tractu infectio tractus urinarii normalis. J Paediatric Infect Dis Soc. MMXX, IX, 305-310. View abstracto.
10. Pincernarum C, M Lau, Gillespie D, et al. Probiotic antibiotic usum in administratione domus curam habitant inter effectus est: A randomized Volume iudicium. JAMA. MMXX, CCCXXIV: 47-56. View abstracto.
11. Zhu XI, Tang XΓ, Qu F, Zheng ego Zhang Thomas, Diao YQ. Bifidobacterium ut prodessem ne Fascitis Enterocolitis in preterm infantes: systematicam review A-analysis et meta. Int J Surg. MMXIX: LXI, 17-25. View abstracto.
12. Wang C D. Fengo medicinales effectus boulardii Homo cum liberis Bifidobacterium cellularum immune munus et acuto fluxus. Ibi Exp Med. MMXIX: XVIII: 2653-2659. View abstracto.
13. A Sharif nomine, n Kashani, Nasri E, Z Soleimani, Sharif MR. Munus Probiotics in curatione dysenteriae dicta sunt: ​​a randomized duplex caecus Fusce Triatio. Probiotics Antimicrob Virus. MMXVII, IX, 380-385. View abstracto.
14. Pruccoli G, E Silvestri, Pacaeus Napoleone C, E Aidala, Garazzino S, C. Numquid Scolfaro epidermidis tutum? Bifidobacterium Bacteremia in puerum cum gravi cor defectum. Infez Med. MMXIX: XXVII: 175-178. View abstracto.
15. E Manzhalii, Virchenko Domine, Falalyeyeva T, T Beregova, Stremmel W. curatio efficaciam a probiotic praeparatorius ad Baptismum non-alcoholico deliberemus steatohepatitis: A gubernatori iudicii. De Dis Romanorum J cap. MMXVII: XVIII: 698-703. View abstracto.
16. Kobayashi ego, Kuhara T, M Oki, Xiao JZ. Bifidobacterium breve de A1 in cognitiva effectus cum adultis maior munus in memoria querelis: a randomized, duplex caecus, placebo-sobrie iudicium. Microbes dicit, ibidem. MMXIX: X: 511-520. View abstracto.
17. Jiang C, B Wang Xia C, et al. A randomized, duplex caecus, placebo-sobrie iudicium ad redigendum severitatem oris a epidermidis Mucositis adductus chemoradiotherapy cum aegris nasopharyngeal carcinoma. Cancer. MMXIX: CXXV: 1081-1090. View abstracto.
18. Inoue T, Y Kobayashi, Mori N; et al. Effectus cognitio coniunctos officium disciplina bifidobacteria suppletionem resistentiam corporis habitus alvum sani senes compositio subiecti. Microbes dicit, ibidem. MMXVIII, IX, 843-853. View abstracto.
19. Dimidi E, A Zdanaviciene, Christodoulides S, et al. Randomized Volume iudicium: Bifidobacterium lactis NCC2818 probiotic nobis placebo, impulsum in ventrem et transit in tempore, signa, longos constipation, in ventrem lactis subsp. Pharmacol alimentum, patris. MMXIX: XLIX: 251-264. View abstracto.
20. Bifidobacterium bifidum quae in effectu yoghurt TABULA dentalis Caglar E. filii bacteria. Clin J Pediatr Deut. MMXIV: XXXVIII: 329-32. View abstracto.
21. Zhang N, M S, S Wu, Guo C, Long S, Tan H. Probiotic Volume effectus est in Gravida mulieres cum diabetes Mellitus Lundoniae Gestational: systematicam review et Meta-analysis randomized dispensata tolleranda. Res J diabete. MMXIX: MMXIX: 5364730. View abstracto.
22. M. Slykerman, Kang J van Zyl N; et al. Mane autem effectus pueritia probiotic suppletionem in cognitione, et morum modus a randomized, placebo-sobrie iudicium. Acta Paediatr. MMXVIII: CVII, 2172-2178. View abstracto.
23. Schmidt RM, Pilmann Laursen R, S Bruun, et al. Probiotics in infantia nuper reducere incidentiae de ECZEMA: A randomized dispensata iudicio. Precursor. MMXIX, XXX, 335-340. View abstracto.
24. Linn YH, Wed KK, Wm NHH. Probiotics enim est effectus praeventionis acutus Radialis-impetravisset, Cervical Cancer aegroti inter Diarrhoea: a randomized placebo-sobrie duplex caecus Study. Probiotics Antimicrob Virus. MMXIX, XI, 638-647. View abstracto.
25. Pro Quid ipsas LK, McIntyre HD, Barrett HL; et al. Probiotics enim Gestational Ne diabetes Mellitus Lundoniae in AUCTARIUM et CORPOROSUS Women: Ab Inventiones ubi erat fons duplex caecus Randomized sobrie iudicium. Diabete Carbonicum. MMXIX: XLII: 364-371. View abstracto.
26. Staudacher HM non ad Lomer MCE, Farquharson FM; et al. A diet humiles in FODMAPs reducit Symptomata in aegroti In Viscus Syndrome et Irritable A Probiotic Restores Species Bifidobacterium: a randomized dispensata iudicio. Gastroenterology. MMXVII: CLIII, 936-947. View abstracto.
27. Matsuoka K, Uemura U, T Kanai, et al. Bifidobacterium breve et efficax per ext lac sublimitatum quod remissio in Ulcerative Colitis seruat. De Dis Romanorum cap ed. MMXVIII: LXIII: 1910-1919. View abstracto.
28. Liu J, Huang NE. Efficacia Bacteria Bifidobacterium tetragenous viable tabellas, cancer aegris est eget constipation. Asian PAC J Virgo Prev. MMXIV: XV: 10241-4. View abstracto.
29. Lau AS, erit N Yanagisawa, Hor yy, et al. Bifidobacterium longum ventrem Microbiota BB536 levaretur respiratorii superioris profile modulantur morbis puerorum in scholis Malaysian praeexistunt. Microbes dicit, ibidem. MMXVIII: IX: 61-70. View abstracto.
30. A ibarra, Barbier Formicinae Latreille, M, N Donazzolo, Pelletier X, Ouwehand c. Bifidobacterium animalis subsp die XXVIII-de effectus. lactis subsp HN019 suppletionem colonic transit in tempore, et signa in gastrointestinal munus in ne constipation vel adultorum, duplici A-caecorum randomized, placebo-sobrie, et potionis iudicium, vndique. Microbes exinterare. MMXVIII, IX, 236-251. View abstracto.
31. Guardamagna Domine, Amaretti A, Puddu PE; et al. Bifidobacteria suppletionem: super plasma lipid profile in dyslipidemic effectus liberi. Nutritionem. MMXIV: XXX (7-8): 831-6. View abstracto.
32. Badehnoosh B, M Karamali, Zarrati M, et al. Probiotic suppletionem in effectis biomarkers inflammatione, per oxidative accentus et graviditate eventus gestational diabete. J Matern Foetus neonati Med. May MMXVIII: XXXI: 1128-1136. View abstracto.
33. Elementum convallis F, M Adamos, Katsafanas E; et al. Adjunctiva probiotic rehospitalization ne Micro-organizati in patientibus acuti furore: A randomized dispensata iudicio. Disord bipolar. Apr 25, MMXVIII View abstracto.
34. Gaudium et Plato, MS Cenci, MS Azevedo, Epifanio M Ionem MH. Bifidobacterium animalis subsp quibus effectus de yogurt. in TABULA dentalis, ut DN ad (CLXXIII)X probiotic lactis et saliva in orthodontic aegris. Res gerit. MMXIV: XLVIII: 63-8. View abstracto.
35. Zamani B, Golkar HR, Farshbaf S, et al. Et metabolicae orci in aegris rheumatoid arthritis suppletionem probiotic responsum est: a randomized, duplex caecus, placebo-sobrie iudicium. Int J Reum MMXVI Diti: XIX: 869-79. View abstracto.
36. Sanchez, Plato mi, Haull GB, Ghajar K, et al. Probiotic Bifidobacterium longum NCC3001 reduces exanimationes incidamus scores cerebrum actio temere et mutatur: in aegris cum autem gubernatori studium iracundior alvus syndrome. Gastroenterology MMXVII: CLIII: 448-459.e8. View abstracto.
37. Karamali M, Dadkhah F, M Sadrkhanlou, et al. Probiotic in glycemic imperium, et suppletionem effectis lipid profile in gestational diabete: a randomized, duplex caecus, placebo-sobrie iudicium. Diabete Metab MMXVI: XLII: 234-41. View abstracto.
38. Jäger R, M Purpura, Stone JD, et al. Haemophilus influenzae Probiotic FP4 et suppletionem BR03 Bifidobacterium breve de dupla sesquitertia et perficientur decrementa, hoc range-of-motus musculus exercitium parcere. MMXVI nutrimentum: VIII. pii, E642. View abstracto.
39. Whorwell PJ, Altringer l J Morellum negotiatorem, et al. Bifidobacterium infantis cum mulieribus In (XXXV)DCXXIV arguit non esse primam orationem probiotic iracundior alvus syndrome. J am Gastroenterol. Iul MMVI, CI, 1581-90. View abstracto.
40. Lau CS Camerario SR. Probiotics est effective a contentionibus prohibendo Cardiobacterium hominis consociata, profusio alvi: systematicam review et meta-analysis. Int J Gen. Med. MMXVI, IX, 27-37. View abstracto.
41. Stenman LK Lehtinen M, N Meland, et al. Probiotic In Fiber Imperium sine seu Corpus Fat Missam, Associated Zonulin Serum et in AUCTARIUM et CORPOROSUS Adulti-randomized dispensata iudicio. EBioMedicine MMXVI: XIII: 190-200. View abstracto.
42. Sato S, T Uchida: Price, S, et al. Cum modo inductus in cloacarum exstrophy Bacteremia Bifidobacterium breve. Pediatr Int. MMXVI: LVIII: 1226-8. View abstracto.
43. Jayasimhan S, NY Yap, Roest N, R Rajandram, Chin KF. Microbial efficacia augeret cellula curriculum transegeritis longos constipation: a randomized, duplex caecus, placebo-sobrie iudicium. Clin Nutr MMXIII: XXXII: 928-34. View abstracto.
44. Han K, Wang J: C. Web: primam orationem Kim H. duplex iactaret epidermidis et iracundior alvus syndrome: a randomized sobrie duplex caecus iudicium. J Gastroenterol. MMXVII: LII: 432-443. View abstracto.
45. HY Chang, Chen Cornelius, Cornelius Chang Lin C, Lin CY, Peng CC. Multa modis epidermidis plurimum videtur esse cavendum ne existeret probiotics in Fascitis Enterocolitis et mortalitas designatur: 'An updated meta-analysis. PLoS unus. MMXVII: XII: e0171579. View abstracto.
46. A Bastürk, Artan R: primam orationem Yılmaz A. synbiotic, probiotic, et treatments pro prebiotic iracundior alvus syndrome in infantes: A randomized dispensata iudicio. Turcae J Gastroenterol MMXVI: XXVII: 439-43. View abstracto.
47. Blaabjerg S: Artzi videlicct DM, Aabenhus R. Ne Probiotics enim in vitro, deiectio Associated outpatients Systematicam Review, et Meta-analysis. Antibiotics (Basileae). MMXVII: VI. View abstracto.
48. Al Faleh K, J. Anabrees Probiotics enim cavendum ne existeret Fascitis Enterocolitis in preterm infantes. Cochrane Database Syst MMXIV, Apoc,, CD005496. View abstracto.
49. E Dimidi, Christodoulides S: Fragkos fcilicet KC, M. Scott, Byrne effectus of probiotics in K ad munus in ne constipation vel adultorum: systematicam review analysis of meta-randomized dispensata ac iudiciis. J am Nutr Clin. MMXIV, C, 1075-84. View abstracto.
50. Wildt S: Et Nordgaard, Hansen U, Brockmann E, Rumessen DD. A randomized duplex caecus, placebo-sobrie iudicium ad V-La Lactobacillus acidophilus et Bifidobacterium animalis subsp. lactis BB-remissionis, in XII ad victum ulcerative COLITIS. J Crohns COLITIS MMXI, V, 115-21. View abstracto.
51. J inter Sen: Zuo Saxo, Mao AP. Of probiotics in effectum inducere in Lorem remissionis et maintaining ulcerative COLITIS, Crohn scriptor morbus et pouchitis: a randomized dispensata meta-analysis iudiciis. Viscus Inflamm disp. MMXIV, XX, 21-35. View abstracto.
52. MS Park, Kwon B, S Ku, Ji GE4. Bifidobacterium longum Bori de efficacia curatio in Infantes, et per Lactobacillus acidophilus AD031 Probiotic Rotavirus falciparum. Nutrimentum. MMXVII: IX. pii, E887. View abstracto.
53. Søndergaard B, Olsson J, K Ohlson, Svensson U, Bytzer P, R. Ekesbo ext lac sublimitatum in signa et effectus probiotic intestinorum Flora et in aegris cum iracundior alvus syndrome: a randomized, placebo-sobrie iudicium. J Seand Gastroenterol MMXI: XLVI: 663-72. View abstracto.
54. Simrén M, Öhman l J Olsson: et al. Orci iudicii: ex quibus effectus de tribus probiotic Bacteria in aegris cum ext lac sublimitatum iracundior alvus syndrome - a randomized, geminus-cæcus, dispensata studiis. Ibi alimentum Pharmacol MMX: XXXI: 218-27. View abstracto.
55. Goldenberg JZ, Lytvyn l J Steurich, Parkin P, S Mahant: Cicero BC. Epidermidis-consociata antibiotic Paediatric in ne fluxus. Cochrane Database Syst MMXV, Apoc,, CD004827. View abstracto.
56. A OnCallaghan, van D. Sinderen Bifidobacteria et munus suum debite implendum, sicut membra humana Viscera Microbiota. Ante familiaris. Iun MMXVI XV: VII: CMXXV. View abstracto.
57. Olivares M, G Castillejo, Varea V, Y. sanzDuplex caecus, randomized, placebo-sobrie iudicium interveniret perpendere consectaria quae ex effectis Bifidobacterium longum Sonim (VII)CCCXLVII apud infantes nuper praecogniti cum coeliacis morbo. J Nutr. Iul MMXIV XIV, CXII: 30-40. View abstracto.
58. Hojsak Ego Tokic Pivac V, Mocic Pavic A, AM Pasini, Create new account S. Bifidobacterium animalis subsp. lactis subsp defecerunt commune ne infectiones in nosocomio liberos: a randomized, duplex caecus, placebo-sobrie studiis. J am Nutr Clin. Mar MMXV, CI, 680-4. View abstracto.
59. Eskesen D, JESPERSEN L, B Michelsen, Whorwell PJ, Lissner S-Graecorum: Morberg CM. Bifidobacterium animalis subsp effectus a probiotic iactabantur. lactis BB-12®, de CACATUS CACATUS frequency in sanus subditis low frequency et abdominis molestiae: a randomized, duplex caecus, placebo-sobrie,-coetus parallel iudicii. J Nutr. MMXV Nov XXVIII: CXIV: 1638-46. View abstracto.
60. Costeloe K, P Loew, Juszczak E, M Wilks, Millar MR; Probiotics est in preterm infantes Study Group on NoDictionaries. Bifidobacterium breve BBG I, in preterm infantes nimis: a randomized dispensata III tempus iudicii. SCALPELLUM. Feb MMXVI XIII, CCCLXXXVII, 649-60. View abstracto.
61. S. Allen, K ciuitatem Warham, Wang D, C Bradley, Hutchings H. W Cicero, Dhar A, B Brown, Foden A, Gravenor MB: Bruno D. Lactobacilli est antibiotic quod bifidobacteria in ne-consociata et deiectio deiectio in senior Cardiobacterium hominis inpeccabilis (placide): a randomized, duplex caecus, placebo-sobrie, multicentre iudicii. SCALPELLUM. Oct MMXIII XII, CCCLXXXII, 1249-57. View abstracto.
62. Roberfroid MB. Et Prebiotics epidermidis, ad munus sunt cibos? J am Nutr Clin. MM; LXXI (Suppl VI) 7S, 1682S; 1688S disputationem, 90S. View abstracto.
63. Wang YH, Huang M. triplex effectus Lactobacillus acidophilus et Bifidobacterium bifidum suppletionem est ad vexillum Lorem Bacillus subtilis subsp pylori in eradication dynamic et in intestinorum Flora mutationes. J Microbiol Biotechnol mundo. MMXIV: XXX: 847-53. View abstracto.
64. Wang ZH, Gao QY, Fang JY. Analysis of meta-efficaciam et salutem Bifidobacterium, Lactobacillus, et quibus continentur probiotic compositis curriculum transegeritis eradication subtilis Lorem. J Gastroenterol Clin. MMXIII: XLVII: 25-32. View abstracto.
65. Videlock EJ, Cremonini F. Nocte Diei Meta-analysis, in antibiotic epidermidis-associatorum fluxus. Pharmacol alimentum, patris. MMXII: XXXV: 1355-69. View abstracto.
66. Tomasz B, S Zoran, Jaroslaw W, Ryszard M, G Marcin, Robert B, K Petri, Lukasz K, P Dareum natura, Petri G, P Przemyslaw Michol D. Long-terminus usum Staphylococcus epidermidis et Bifidobacterium habet effectum in prophylactic pouchitis occursus et severitas: a randomized studium futurum. Res Biomed Int. MMXIV: MMXIV: (CCVIII)LXIV. View abstracto.
67. Shavakhi A, E Tabesh, Yaghoutkar A, B Hashemi, Tabesh F, M Khodadoostan, Minakari M, Shavakhi S: Et A. Gholamrezaei effectis multistrain probiotic bismuth compositis, in quibus quadruplicem Lorem Bacillus subtilis subsp pylori infectio ut: a randomized placebo-sobrie triplici -blind studium. Bacillus subtilis subsp. MMXIII: XVIII: 280-4. View abstracto.
68. Rerksuppaphol S: Rerksuppaphol commune frigus L. randomized dispensata iudicio epidermidis ad redigendum in Scholárum. Pediatr Int. MMXII: LIV: 682-7. View abstracto.
69. Rautava S, E Kainonen, Salminen S, E Isolauri probiotic suppletionem matris in graviditate ac loricam pascens reducit periculo scabie quoque in infantibus assimilatur. J Allergy Neuroimmunol Clin. MMXII, CXXX, 1355-60. View abstracto.
70. Langkamp Henken, B, C Rowe Mores: Ford AL abscissi Christman Regina vel vulgò coluntur C Jr Khouri L, G, J Specht Girardo SA Spaiser SI, Dahl WJ. Bifidobacterium bifidum R0071 praecessi in a major pars de inferioribus, et sanus dies quotus quisque dies frigidis reporting alumni academia illustraverat / flu: a randomized, duplex caecus, placebo-sobrie studiis. J Nutr. XIV MMXV; CXIII, 426-34. View abstracto.
71. Cruore C, A Custovic, Tannock VUL Munro K, Maxime G, K Cicero, Cicero C, Horatius J: C Chalonerus, CS Murray, Praxi A. Treatment et cohibitionem secundarium seu Bifidobacterium lactis Lactobacillus paracasei epidermidis effectus in ECZEMA in primis infans : randomized dispensata iudicio, cum sequantur usque aetatem annorum III. Clin Exp Allergy MMXII: XLII: 112-22. View abstracto.
72. Carrocera Fernandez-la: A Solis-Herrera, Ayón Cabanillas, M, Gallardo Sarmiento, RB, García-Pérez CS, Rodriguez-R Montaño, Echániz Aviles, MO. Duplex caecus, randomized Volume coeperimus aestimare quanti efficacitati probiotics in preterm recenter natorum minus quam MD g pondus in prohiberent necrotising Enterocolitis. Foetus arcus dis Puellula neonati MMXIII Ed: XCVIII: F5-9. View abstracto.
73. Begtrup LM, de Muckadell OB Kjeldsen J, Christensen RD, de Jarbøl. Long-term treatment cum probiotics in primaria cura cum aegris iracundior alvus syndrome - a randomized, duplex caecus, placebo dispensata iudicio. J Seand Gastroenterol MMXIII: XLVIII: 1127-35. View abstracto.
74. S. Allen, Jordan S, M Storey Thornton CA, Gravenor MB, Garaiova Ego Carolus Plummer SF, Wang D, G. Morgan Probiotics in ne ECZEMA: a randomized dispensata iudicio. Arcus dis Puellula MMXIV, XCIX, 1014-9. View abstracto.
75. De RR.Singh M, N. Shafiq Probiotics in curatio allergic RHINITIS. Allergy mundo Unitarum Journal MMX, III: 239-244.
76. Seki M, T Igarashi Fukuda Simamura S A T Kaswashima Ogasa K effectus lac est excultus, in Bifidobacterium "ordinis" senem coetus in medio. Nutr Foodstuff MCMLXXVIII: XXXI: 379-387.
77. Kageyama T, T Nakano A Comparative Study Tomoda in oralis administratione Quidam Bifidobacterium Apparatum. Et medicina Latina (Japan) MCMLXXXVII, CXV, 65-68.
78. Kageyama T, T Tomoda Nakano Y graeci Bifidobacterium Administration effectus in patientibus leukemia. Aspergillus niger Bifidobacteria. MCMLXXXIV, III, 29-33.
79. J Ballongue, Grill Baratte J-actio Euloge P. de la flore intestinale laits fermentés an Bifidobacterium. Lait MCMXCIII, LXXIII, 249-256.
80. Vestibus amicire, T, M Kingaku Yaeshima T Teraguchi Fukuwatari S A T Lino Fujisawa H H. Hayasawa Ishibashi N effectum in administratione intestinorum Bifidobacterium longum BB536 yogurt a sanus environment adultis. Salutem Microb Ecol Dite patre MCMXCIX, XI, 41-46.
81. Tomoda T, Y Nakano Kageyama C. Credo in greges perpaucos congestae in intestinorum Flora et assidua scilicet seu Mammalia medicamentis Administration of Anticancer. Et medicina Latina (Japan) MCMLXXXI; CIII: 45-49.
82. Tomoda T, Y Nakano Kageyama M. Contra intestinorum Aspergillus Aspergillus umbram, et Leukemia Virus in in aegroti: Effectus Bifidobacterium Administration. Aspergillus niger Bifidobacteria MCMLXXXVIII, VII, 71-74.
83. Araya, Rosita Kojima, Rosita Yaeshima Ishibashi Norio Shimamura Seiichi Hayasawa Hirotoshi. Nocivum inhibitory effectus in intestinorum Bacteria Bifidobacterium longum BB536. Aspergillus niger Bifidobacteria MCMXCV, XIV, 59-66.
84. Namba K, N Ishibashi Hayasawa HN T Yaeshima Yamazaki Shoji. Bifidobacterium longum in inhibitory effectus Enterohemorrhagic Mus O157: H7. Aspergillus niger et Lichenologicae MMIII: XXII, 85-91.
85. Igarashi M, R Iiyama Kato Tomita M y N Asami Ezawa I. Effectus Bifidobacterium longum et lactulose in robore os ovariectomized Osteoporosis in exemplum rates. Bifidus MCMXCIV, VII, 139-147.
86. Yaeshima T, N Hiramatsu Ishibashi Takahashi S K Nakagawa Ota S A T Ohashi Hayasawa H H. Iino effectum CACATUS frequency et dulce in fecal BB536 yogurt Bifidobacterium longum quibus adultis sanus habitus: Dicendum quod comparatio cum yogurt dulcis vexillum. Kenko Eiyo Shokuhin Kenkyu MCMXCVIII, I (3/4): 29-34.
87. Yaeshima T, S Takahashi Matsumoto N Ishibashi Hayasawa N, H H. Lino yogurt quibus effectus in intestinorum Bifidobacterium longum BB536 amet, CACATUS frequency fecal notae: A vexillum collatio cum yogurt. Aspergillus niger Biosci MCMXCVII; XVI, 73-77.
88. Xiao J, K Yaeshima Miyaji T T Iwatsuki Odamaki Kondol S K, H Togashi effectum conflictus Epistulae M. crebriores yogurt quibus Bifidobacterium longum BP DXXXVI in fecal ex defaecatione habet sanus adultorum, vir duplex crux super caecus studio. Acta Bacteria MMVII, XVIII, 31-36.
89. T Yaeshima, Takahashi Ogura S A T Konno Iwatsuki K Ishibashi Hayasawa H. N effectum CACATUS Non ext lac sublimitatum in BB536 Bifidobacterium longum Quibus adultis saluberrimos in Frequency et Fecal proprietates. Acta nutritionis cibum MMI, IV, 1-6.
90. Vestibus amicire, T, K Yaeshima Anjitsu Nakamura T T Takahashi Fukuwatari S A T Ishibashi N Hayasawa Fujisawa Iino H. H administrationis effectus in intestinorum Bifidobacterium longum BB536 amet, and frequency CACATUS fecal hominum naturam omnium voluntariorum fuit. Aspergillus niger Biosci MCMXCVII; XVI, 53-58.
91. Iwabuchi N, N Hiruta Kanetada Yaeshima S K Yasui H. T Iwatsuki Effectus Intranasal Administration of Bifidobacterium longum BB536 mucosal immune ratio in in tractus respiratorii et in GRAVEDO virus Herpesvirus Into. Scientia MMIX lac, XXXVIII, 129-133.
92. Sekine Ego N Takanori Homma Yoshiwara S S. II Tonosuka Bifidobacterium effectibus, de quibus lac Quimioluminiscencia reactionem periphericis leukocytes corpuscular volumen et medium rubrum sanguinem cellulis - a partes maxime Bifidobacterium macrophages in activation. Therapeutics (Japan) MCMLXXXV, XIV, 691-695.
93. Singh, J., Rivenson, A., Tomita, M., Shimamura, S., Ishibashi tuarum N. et Reddy, BS Bifidobacterium longum est, LACTEOLUS acid bacteria, producendo inhibits alvum colonia cancer et modulatur biomarkers ex colonia in medium carcinogenesis . Carcinogenesis MCMXCVII: XVIII: 833-841. View abstracto.
94. Reddy, et Rivenson S. B., A. Potencial effectus a colonia Bifidobacterium longum est, mammarum, iecoris et amino-II-III-methylimidazo carcinogenesis adductus [4,5-f] quinoline a cibis mutagen. Res cancer. 9-1-1993: LIII: 3914-3918. View abstracto.
95. Yamazaki, S., Machii, K., Tsuyuki, S., Momose, H., Kawashima, T., and Ueda, respondeo ut monoassociated C. Bacteria Bifidobacterium longum et ne relatione ad bacterial incursio. Inmunología MCMLXXXV, LVI: 43-50. View abstracto.
96. Kondo, J., Xiao, J. A., Shirahata, A., Baba, M. Abe, A., Ogawa, K., et Shimoda T. modulatory CACATUS effectus of Bifidobacterium longum BB536 super senes aegros accepto in Enteral praesepia servant. J mundo Gastroenterol 4-14-2013: XIX: 2162-2170. View abstracto.
97. Akatsu, H., Iwabuchi famulam tuam N., Xiao JZ, Matsuyama, Z., Kurihara, R., Okuda, K., Yamamoto, T., et Maruyama, Volume M. Effecta Probiotic Bifidobacterium longum et in immune munus BB536 Contra intestinorum aetate Microbiota in aegroti accepit tube Enteral Insecta. J JPEN Parenter Enteral Nutr 11-27-2012; View abstracto.
98. Odamaki T. Sugahara, H., Yonezawa, S., Yaeshima T. Iwatsuki, K., Tanabe, S., Tominaga T. Togashi, H.: Epistulae M. et Xiao JZ Effectus de quibus oris attractio yogurt Bifidobacterium longum BB536 in numero a cellula in Microbiota enterotoxigenic Bacteroides fragilis. Nautilus pompilius. MMXII: XVIII: 14-18. View abstracto.
99. Iwabuchi famulam tuam N., Xiao, J. A., Yaeshima, T., and Iwatsuki, et Mammalia C. Bifidobacterium longum ameliorates GRAVEDO virus infectio est in mures. Biol.Pharm.Bull. MMXI, XXXIV, 1352-1355. View abstracto.
100. Simakachorn famulam tuam N., Bibiloni, R., Yimyaem, P., Tongpenyai, Y., Varavithaya, W., Grathwohl, D., Reuteler, G., Maire, C, Blum, S., Steenhout, P., Benyacoub J. et SCHIFFRIN, EJ Tolerantia salutem, per effectum faeculentia Microbiota Enteral epidermidis in forma et pre- suppletus ualde infirmorum filii. J Pediatr.Gastroenterol.Nutr. MMXI: LIII: 174-181. View abstracto.
101. Hascoet, J. M. Hubertum, C., Rochat, P., Legagneur, H., Gaga, S., Emady, Azar, S., et Steenhout P G. effectum conflictus compositionem formula in ventrem Microbiota progressionem sive sonorum formatione. J Pediatr.Gastroenterol.Nutr. MMXI: LII: 756-762. View abstracto.
102. Firmansyah, A., Dwipoerwantoro P G., kadim, M., Alatas, S.: Conus, N. Lestarina L., Bouisset, F, et Steenhout P. Amplio incrementum lac continet de toddlers pavit synbiotics. Pac.J Clin.Nutr Asia. MMXI, XX, 69-76. View abstracto.
103. Tang, L. M., Lahtinen: S. J., et Boyle, R. et J. Probiotics prebiotics; orci in allergic morbo effectus. Curr.Opin.Pediatr. MMX: XXII: 626-634. View abstracto.
104. Namba, K., Hatano, M., Yaeshima T. takase: M. et Suzuki C. Effectus Bifidobacterium longum BB536 in administratione influenza infectio, GRAVEDO Vaccinum falciparum titer et senes cellula-mediata immunitatem. Biosci.Biotechnol.Biochem. MMX: LXXIV: 939-945. View abstracto.
105. Gianotti L., Morelli, L., Galbiati, P., Rocchetti, S., Coppola, S., Benedikt, A., Gilardini, C., Zonenschain, D., Nespoli: A. et sz'bl subdųis, dummodo M. A randomized duplex caecus iudicium, supra de administratione Perioperative probiotics in colorectal cancer aegris. J Gastroenterol mundo. 1-14-2010: XVI: 167-175. View abstracto.
106. Andrade, et S. Borges, n Effectus quibus lactis Lactobacillus acidophilus Bifidobacterium longum et mediocriter elevantur super plasma lipids et cholesterol, aut normalis in mulieribus. Res J.Dairy. MMIX: LXXVI: 469-474. View abstracto.
107. Danckerts, C., Piloquet, H., Butel, FA, Berger, B., Rochat, F, Ferraris, L., De: C. Robert, Legrand, A., de la Cochetiere, MF, N'Guyen, JM Vodovar M. Voyer M. Darmaun D. et Wit JC ortus humili-oris suppletionem cum ipso pondere epidermidis preterm infantes a randomized duplex caecus, placebo-sobrie iudicium. Am.J Clin.Nutr. MMIX: LXXXIX, 1828-1835. View abstracto.
108. Iwabuchi famulam tuam N., Takahashi famulam tuam N., Xiao JZ, Yonezawa, S., Yaeshima T. Iwatsuki, K., et Hachimura: S. suppressive Bifidobacterium longum est productio ex effectis Th2 adductus est T-attracting Chemokines gene-cellula, exhibere cell interactions. FEMS Immunol.Med.Microbiol. MMIX, LV, 324-334. View abstracto.
109. Takeda, Y., Nakase, H., Namba, K., Inoue, S., Ueno, S., UzA tuarum N. et Chiba T T-bet Upregulation est stricta et coniunctas in Bifidobactrium moleculis elit longum improves colonic de ulcerative COLITIS. Inflamm.Bowel.Dis. MMIX, XV, 1617-1618. View abstracto.
110. Soh, quam Aquilo: Re: M., Gerez, I., Chong, YS, Rauff, M., Ng, YP, Wong, HB Phou famulam tuam N., Lee, NY, et Shek LP Probiotic suppletionem in primo VI Asian in mensibus in periculo parvulorum neces - effectus in ECZEMA et atopic sensitisation ad I anno aetatis suae. Clin.Exp.Allergy MMIX: XXXIX: 571-578. View abstracto.
111. Odamaki, T, Xiao JZ, Sakamoto, M., Kondo, S., Yaeshima T. Iwatsuki, K., Togashi, H., Enomoto, T., and Epistulae M. distribuit in diversis speciebus Bacteroides fragilis est hominum coetus in Iaponica pollinosis medullam cedri. Appl.Environ.Microbiol. MMVIII, LXXIV, 6814-6817. View abstracto.
112. Del Giudice, et Brunese M. M., G. p Probiotics, prebiotics; et urna in filios, quid novi in ​​ultimo anno? J Clin.Gastroenterol. MMVIII, Suppl III XLII II Petr: S205-S208. View abstracto.
113. Chouraqui, JP Grathwohl D. Labaune JM, Hascoet JM DE Montgolfier ego Leclaire M. Giarre M. et Steenhout P. Sicurez spe patientiae, et alia nascitur ultionem quibus formulis, sive sonorum formatione mixturae epidermidis epidermidis et prebiotics in randomized dispensata iudicio. Am.J Clin.Nutr. MMVIII, LXXXVII, 1365-1373. View abstracto.
114. Matsumoto, T, Ishikawa, H., Tateda, K., Yaeshima T. Ishibashi tuarum N. et Yamaguchi, et Mammalia C. Bifidobacterium longum prohibet convenientiam in ventrem propriae Yersinia pestis SEPSIS mures inclusi essent. J Appl.Microbiol. MMVIII: CIV: 672-680. View abstracto.
115. Odamaki, T, Xiao JZ, Iwabuchi famulam tuam N., Sakamoto, M., Takahashi famulam tuam N., Kondo, S., Miyaji, K., Iwatsuki, K., Togashi, H., Enomoto, T., and Epistulae ex influentia Y. Bifidobacterium longum BB536 attractio faeculentia Microbiota Italica in indiuiduis cedro pollinosis pollinis in tempore. J Med.Microbiol. MMVII, LVI Romani (X) 1301-1308. View abstracto.
116. Iwabuchi famulam tuam N., Takahashi famulam tuam N., Xiao, J. A., Miyaji, K., et Iwatsuki, K Fungi-independens TH1 cytokine Th2 suppressive bifidobacteria effectis. Microbiol.Immunol. MMVII: LI: 649-660. View abstracto.
117. Xiao JZ, Kondo, S., Takahashi famulam tuam N., Odamaki T. Iwabuchi famulam tuam N., Miyaji, K., Iwatsuki, K., et Enomoto T. Mutationes temporum linunt fucoque et ligna cedrina Iaponica in campestribus quoque et in plasma TARC signum est relationes development. Int.Arch.Allergy Immunol. MMVII, CXLIV, 123-127. View abstracto.
118. Odamaki, T, Xiao JZ, Iwabuchi famulam tuam N., Sakamoto, M., Takahashi famulam tuam N., Kondo, S., Iwatsuki, K., Kokubo, S., Togashi, H., Enomoto, T., and Epistulae ex Italica in singulis tabulatis cedrinis Y. fluctuationem fecal Microbiota pollinosis pollinis in tempore gratia probiotic attractio. J Investig.Allergol.Clin.Immunol. MMVII: XVII: 92-100. View abstracto.
119. Xiao JZ, Kondo, S., Yanagisawa famulam tuam N., Miyaji, K., Enomoto, K., Sakoda T. Iwatsuki, K., et Enomoto T. Volume curatio efficaciam probiotic Bifidobacterium longum ad salubria Iaponica de medulla cedri pollen allergy est in subiecto, aestimanda et nuditate environmental unitas. Allergol.Int. MMVII, LVI: 67-75. View abstracto.
120. Puccio, G.: Cajozzo, C., Meli, P., Rochat, P., Grathwohl, D., et Steenhout P. de nova starter Disputatio Formulae iudicium continet de infantibus et prebiotics BL999 Bifidobacterium longum vivere. MMVII nutritionem: XXIII: 1-8. View abstracto.
121. Xiao JZ, Kondo, S., Yanagisawa famulam tuam N., Takahashi famulam tuam N., Odamaki T. Iwabuchi famulam tuam N., Miyaji, K., Iwatsuki, K., Togashi, H., Enomoto, K., et Enomoto T. Probiotics est in treatment of Iaponica pollinosis tabulatis cedrinis: a duplex caecus, placebo-sobrie iudicium. Clin.Exp.Allergy MMVI, XXXVI, 1425-1435. View abstracto.
122. Xiao JZ, Kondo, S., Yanagisawa famulam tuam N., Takahashi famulam tuam N., Odamaki T. Iwabuchi famulam tuam N., Iwatsuki, K., Kokubo, S., Togashi, H., Enomoto, K., et Enomoto T. effectum conflictus probiotic Bifidobacterium longum BB536 [correximus] levanda Volume symptoms et campester of Iaponica modulantes plasma cytokine pollinosis cedrus in tempore pollen. A randomized, duplex caecus, placebo-sobrie iudicium. J Investig.Allergol.Clin.Immunol. MMVI: XVI, 86-93. View abstracto.
123. Bennet, R., Nord, C. E. et Zetterstrom: Transiens R. coloniam deductam ex infantibus recens natis; in ventrem quod bifidobacteria lactobacilli administratum viva voce. Acta Paediatr. MCMXCII, LXXXI, 784-787. View abstracto.
124. Zsivkovits, M., Fekadu, K., Sontag, G.: Nabinger, II, Huber, WW, Kundi, M., Chakraborty, A., Foiseio, H. et Knasmuller: Ne S. heterocyclic adductus-amine a mures inclusi essent et iecur damnum per colonia DNA in Corynebacterium diversis modis. Carcinogenesis MMIII: XXIV: 1913-1918. View abstracto.
125. Orrhage, K., Sjostedt, S., et Nord, C. C. supplemento effectus in intestinorum microflora super LACTEOLUS acid bacteria quod oligofructose in administrandae Cefpodoxime proxetil. J Antimicrob.Chemother. MM: XLVI: 603-612. View abstracto.
126. Xiao JZ, Takahashi S, T Odamaki, et al. Antibiotic susceptione bifidobacterial Iaponica conatibus distribui in foro.Biosci Biotechnol Mol. MMX: LXXIV: 336-42. View abstracto.
127. AlFaleh K, Anabrees J, Bassler D, Al-T Kharfi Probiotics enim cavendum ne existeret Fascitis Enterocolitis in preterm infantes. Cochrane Database of Nomina Systematica Recensiones MMXI, Part 3. Ars. No .: CD005496. DOI: 10.1002 / 14651858.CD005496.pub3. View abstracto.
128. Tabbers MM Milliano Ego Roseboom MG, Benninga MA. Bifidobacterium breve est effective a pueritia in curatio constipation? Et ex gubernatori studium. J Nutr MMXI, X, XIX. View abstracto.
129. Leyer G, S Li, ​​Mubasher ME, et al. Probiotic effectus in frigus et INFLUENZA-amo symptoms Incidentiæ & duratione in filios. Pediatrics MMIX, CXXIV, e172-e179. View abstracto.
130. Miele E, F Pascarella, Giannetti E. et al. Effectus a probiotic praeparatio (VSL # III) ad Inductionem fac remissionis, in sustentationem et ad filios ulcerative COLITIS. J am Gastroenterol MMIX: CIV: 437-43. View abstracto.
131. T Kuhbacher, Ott SI, Helwig U, et al. Et fungal ut probiotic Bacteria in relatione Microbiota Lorem (VSL # III) in pouchitis. Viscera MMVI, LV, 833-41. View abstracto.
132. R Bibiloni, RN cft aequalis Fedorak, Tannock VUL, et al. Probiotic VSL # III-mixtisque inducit in remissionem donationem cum aegris activae ulcerative COLITIS. Gastroenterol MMV J: C: 1539-46. View abstracto.
133. A Tursi, Brandimarte G, GM Giorgetti, et al. Humilis-dose balsalazide plus summus potentia a probiotic praeparentur efficaciora esse solus vel balsalazide Mesalazine in curatio acuti mitioris ingenii esse moderatum ulcerative COLITIS,. Med Sci Monit MMIV: X: PI126-31. View abstracto.
134. Kato K, S Mizuno, Umesaki ego, et al. Randomized, placebo-sobrie iudicium bifidobacteria ex ext lac sublimitatum in perpendendis effectus activae ulcerative COLITIS. Ibi alimentum Pharmacol MMIV, XX, 1133-41. View abstracto.
135. Gale Ecco superior. Meta-analysis of probiotics in ne et curatio fluxus et adiuncti antibiotic Clostridium difficile morbo. J am Gastroenterol MMVI, CI, 812-22. View abstracto.
136. O'Mahony l J McCarthy, Kelly P, et al. Bifidobacterium in Lactobacillus bacteriophage et iracundior alvus syndrome, respondeo quod indicium est necessitudo cytokine profiles. Gastroenterology MMV, CXXVIII, 541-51. View abstracto.
137. Ishikawa II, Akedo ego, ego Umesaki, et al. Randomized dispensata iudicio, ad effectum de bifidobacteria ext lac sublimitatum in ulcerative COLITIS. J AM Coll Nutr MMIII: XXII, 56-63. View abstracto.
138. A. Rastall. Bacteria in ventrem: Favorem tam hostium quam amicorum modo et mutare statera. J Nutr MMIV, CXXXIV: 2022S, 2026S. View abstracto.
139. Mimura T, F Rizzello, Helwig U, et al. Cum cotidie summus Lorem consectetuer probiotic (VSL # III) ad servandum sensum recurrentes, seu remissio pouchitis parebant. MMIV ventrem: LIII: 108-14. View abstracto.
140. Cremonini F, De Caro S, M Covino, et al. Aliud est effectus anti-apparatus probiotic Bacillus subtilis subsp pylori-related Lorem parte effectus, in parallel coetus, tria caecus, placebo-sobrie studiis. J am Gastroenterol MMII: XCVII: 2744-9. View abstracto.
141. A Abbate Glocestriab Episcopi, Barkholt Domino, Nord CE. Lactobacillus acidophilus, Bifidobacterium lactis Lactobacillus f19 ne antibiotic, consociata adipiscing motus Bacteroides fragilis, in intestinum. J Antimicrob Chemother MMIII: LII: 308-11. View abstracto.
142. Kim HJ, Camilleri M, McKinzie S, et al. A randomized dispensata iudicio a probiotic, VSL # III, in ventrem et transit symptoms, alvum plurimum iracundior alvus syndrome. Ibi alimentum Pharmacol MMIII: XVII: 895-904. . View abstracto.
143. Roberfroid MB. Et Prebiotics epidermidis, ad munus sunt cibos? Clin J am Nutr MM; LXXI: 1682S, 7S. View abstracto.
144. Gionchetti P: Rizzello F, A Venturi, et al. Curatio in patientibus longos bacteriotherapy oris sustentationem pouchitis: Vir duplex caecus, placebo-sobrie iudicium. Gastroenterology MM; CXIX: 305-9. View abstracto.
145. Rautio M, Jousimies Helcias-II, Kauma S, et al. Abscess ex Lactobacillus rhamnosus GG iactabantur distingui ab L. rhamnosus iactabantur. Clin Infect Dis MCMXCIX: XXVIII: 1159-60. View abstracto.
146. Goldin rectae BR. Health Beneficium of probiotics. J Nutr MCMXCVIII: LXXX: S203-7. View abstracto.
147. Kalima P. Masterton RG, Roddie P, et al. Lactobacillus rhamnosus infectio in medullae ossium PLANTO puero hoc. J Infect MCMXCVI: XXXII: 165-7. View abstracto.
148. Saxelin M, Chuang NH, Chassy B, et al. Lactobacilli Bacteremia et meridionali sunt in Finland 1989-1992. Clin Infect Dis MCMXCVI: XXII: 564-6. View abstracto.
149. S. Ludovici libertus = Syr. Review articulum, et uti agentium biotherapeutic in gastrointestinal morbo ne et curatio. Ibi alimentum Pharmacol MCMXCVIII, XII, 807-22. View abstracto.
150. Meydani SN: Vah WK. Immunologic effectis yogurt. Clin J am Nutr MM; LXXI, 861-72. View abstracto.
151. Isolauri E, T Arvola, Sutas ego, et al. Atopic ECZEMA in Probiotics est procuratio. Clin Exp Allergy MM: XXX: 1604-10. View abstracto.
152. Korschunov VM, Smeyanov TE DEUM LAUDAMUS TE: Efimov BA, et al. Apparatu usus medicinales antibiotic repugnans Bifidobacterium patere hominibus altum gamma-radius consectetuer. J med Microbiol MCMXCVI: XLIV: 70-4. View abstracto.
153. Venturi A, Gionchetti P, F Rizzello, et al. Flora Orientalis incidat in compositionem faeculentia, a probiotic novum comparandum habeant: praevia notitia super curatio de patientibus sustentationem ulcerative COLITIS. Ibi alimentum Pharmacol MCMXCIX: XIII: 1103-8. View abstracto.
154. Phuapradit P: Varavithya W, K Vathanophas, et al. Adiciunt, acceptis parvulis vitium Rotavirus reductionem bifidobacteria formula. J Med Assoc Thai MCMXCIX: LXXXII: S43-8. View abstracto.
155. Hoyos AB. Reducere incidentiae de Fascitis Enterocolitis consociata cum Enteral Bifidobacterium infantis and administration of Lactobacillus acidophilus neonates sunt per intensive cura unitas. Int J Infect Dis MCMXCIX, III: 197-202. View abstracto.
156. A. lumen terebramus acuto In American Pharmaceutical Association Naturalis Guide ad medicinam. Novi Eboraci: Stonesong Press, MCMXCIX: XIX.
157. Chen RM, JJ Wu, Lee: SC; et al. Auget intestinorum Bifidobacterium et suppressio Ecclesiarum COLIFORM bacteria yogurt est brevis-term ingestion. Lacticiniis Sci MCMXCIX J: LXXXII: 2308-14. View abstracto.
158. Hem, IL, Yang CH, poniturque Kim II, Chong V. Mancini causam in SEPSIS fecit Bifidobacterium longum. Clin Microbiol MCMXCIX J: XXXVII: 1227-8. View abstracto.
159. C. Colombel, Cortot A, C Neut, Romond C. Yoghurt Bifidobacterium longum et reduces atenolol effectus gastrointestinal effecerunt. MCMLXXXVII Lance, II: XLIII.
160. Hirayama K, Rafter J. probiotic Bacteria in partes in cancer ne. Microbes Infect MM: II, 681-6. View abstracto.
161. MACFARLANE GT: Sumptibus Cummings. Probiotics et prebiotics; dirigere actiones intestinorum Bacteria can beneficium salutis? BMJ MCMXCIX, CCCXVIII: 999-1003. View abstracto.
162. Chiang BL indicentium, Sheih YH, Wang Horarum, editio et al. Enhancing puritate alimentorum consummatio per immunitatem a probiotic LACTEUS acidum Bacteria (Bifidobacterium lactis subsp HN019): et ipsum definitionem cellularum immune respondeo. Clin J Nutr MM: LIV: 849-55. View abstracto.
163. Aurelius Clemens V, Peiffer Ego Hudault S, et al. Bifidobacterium infantis habitans ab hominibus inventis ulteriora Exert antimicrobial operatio gastrointestinal microflora. MM ventrem: XLVII: 646-52. View abstracto.
164. Arunachalam K, HS Gill, Thomas Chandra. In puritate alimentorum consummatio de naturalis consecraverant ad instaurationem immune munus Bifidobacterium lactis (HN019). Clin J Nutr MM: LIV: 263-7. View abstracto.
165. Bouhnik N, P Pochart, Marteau P, et al. Recuperatio of fecal in hominibus et sicera non viable bifidobacterium ingested in lac. Gastroenterology MCMXCII, CII, 875-8. View abstracto.
166. Saavedra Babylon, et al. Bifidobacterium bifidum nutricatu numerum octoginta et Haemophilus influenzae parvulis in hospitium nam et ne fluxus sanguinis fusione Rotavirus. SCALPELLUM MCMXCIV, CCCXLIV, 1046-9. View abstracto.
167. Scarpignato C, p Rampal Ne et curatio fluxus viator est: A pharmacological orci elit. Plasmodium falciparum MCMXCV: XLI: 48-81. View abstracto.
168. Elmer VUL, Surawicz CM, Gale Ecco superior. Agentia Biotherapeutic: A neglectus modus usurpetur pro habendo et cohibitionem lectus intestinis et vaginal infectiones. JAMA MCMXCVI, CCLXXV, 870-5. View abstracto.

From Review - 11/25/2020